Drug
VX 150
VX 150: highest development phase Phase 2, developed by Vertex Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VX-150 NCT03764072 | Phase 2 | Acute Pain |
| VX-150 NCT06420765 | Phase 1 | Pain |
Latest
No recent events.
Follow VX 150 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.